Dr.reddy's Laboratories Ltd — Fexofenadine Exporter Profile
Indian Pharmaceutical Exporter · #4 for Fexofenadine · $12.4M export value · DGFT Verified
Dr.reddy's Laboratories Ltd is the #4 Indian exporter of Fexofenadine with $12.4M in export value and 249 verified shipments. Dr.reddy's Laboratories Ltd holds a 11.4% market share in Fexofenadine exports across 5 countries.
Dr.reddy's Laboratories Ltd — Fexofenadine Export Profile: Buyers & Destinations
Where Does Dr.reddy's Laboratories Ltd Export Fexofenadine?
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED KINGDOM | $9.1M | 246 | 92.8% |
| AUSTRALIA | $254.7K | 23 | 2.6% |
| UNITED STATES | $250.0K | 7 | 2.6% |
| NEW ZEALAND | $194.8K | 16 | 2.0% |
| BRAZIL | $2.6K | 5 | 0.0% |
Dr.reddy's Laboratories Ltd exports Fexofenadine to 5 countries. The largest destination is UNITED KINGDOM accounting for 92.8% of Dr.reddy's Laboratories Ltd's Fexofenadine shipments, followed by AUSTRALIA (2.6%) and UNITED STATES (2.6%). These destinations reflect Dr.reddy's Laboratories Ltd's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Fexofenadine from Dr.reddy's Laboratories Ltd?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| MOVIANTO UK LTD | UNITED KINGDOM | $6.2M | 168 |
| MOVIANTO UK LTD, | UNITED KINGDOM | $1.4M | 33 |
| MOVIANTO UK LIMITED | UNITED KINGDOM | $1.3M | 39 |
| REED-LANE INC | UNITED STATES | $200.0K | 4 |
| DR.REDDYS LABORATORIES (AUSTRALIA) | AUSTRALIA | $149.9K | 9 |
| MOVIANTO UK LIMITED, | UNITED KINGDOM | $145.0K | 6 |
| DR.REDDY'S LABORATORIES (AUSTRALIA) | AUSTRALIA | $95.4K | 12 |
| DR.REDDYS NEWZEALAND LIMITED | NEW ZEALAND | $56.5K | 6 |
| DR REDDY'S NEWZEALAND LIMITED | NEW ZEALAND | $51.9K | 2 |
| REED - LANE INC 359 NEW WARK, PROMP | UNITED STATES | $50.0K | 1 |
Dr.reddy's Laboratories Ltd supplies Fexofenadine to 19 buyers globally. The largest buyer is MOVIANTO UK LTD (UNITED KINGDOM), followed by MOVIANTO UK LTD, (UNITED KINGDOM) and MOVIANTO UK LIMITED (UNITED KINGDOM). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Fexofenadine Export Value and How Much Does Dr.reddy's Laboratories Ltd Contribute?
India exported $81.9M worth of Fexofenadine through 4,236 shipments from 224 suppliers to 97 countries, serving 599 buyers globally. Dr.reddy's Laboratories Ltd contributes $12.4M to this total, accounting for 11.4% of India's Fexofenadine exports. Dr.reddy's Laboratories Ltd ships Fexofenadine to 5 countries through 19 buyers.
What Is the Average Shipment Value for Dr.reddy's Laboratories Ltd's Fexofenadine Exports?
Dr.reddy's Laboratories Ltd's average Fexofenadine shipment value is $50.0K per consignment, based on 249 shipments totaling $12.4M. The largest destination is UNITED KINGDOM (92.8% of Dr.reddy's Laboratories Ltd's Fexofenadine exports).
How Does Dr.reddy's Laboratories Ltd Compare to Other Indian Fexofenadine Exporters?
Dr.reddy's Laboratories Ltd ranks #4 among 224 Indian Fexofenadine exporters with a 11.4% market share. The top 3 exporters are IND SWIFT LIMITED ($14.6M), CIPLA LIMITED ($13.6M), DR.REDDY'S LABORATORIES LTD ($12.4M). Dr.reddy's Laboratories Ltd processed 249 shipments to 5 destination countries.
What Fexofenadine Formulations Does Dr.reddy's Laboratories Ltd Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| FEXOFENADINE HYDROCHLORIDE 180MG FILM-CO | $1.2M | 29 |
| FEXOFENADINE HYDROCHLORIDE 120MG FILM-CO | $676.7K | 17 |
| FEXOFENADINE HYDROCHLORIDE 180MG FILM-COATED TABLETS 30S (140727X30S=4221810 NOS) | $350.0K | 7 |
| FEXOFENADINE HCL 60MG AND PSEUDOEPHEDRIN | $200.0K | 4 |
| FEXOFENADINE HYDROCHLORIDE 180MG FILM-COATED TABLETS 30S (76738 X 30S PACKS=2302140 NOS) | $150.5K | 4 |
| FEXOFENADINE 120MG HISTALLAY 10S OTC UK(90112 X 10S PACKS=901120 NOS)NOS | $150.0K | 3 |
| FEXOFENADINE 120MG HISTALLAY 10S OTC UK(784210 X 10S PACKS=784210 NOS)NOS | $149.4K | 3 |
| FEXOFENADINE HYDROCHLORIDE 180MG FILM-COATED TABLETS 30S (114887 X 30S PACKS = 3446610 NOS)NOS | $143.0K | 3 |
| FEXOFENADINE HYDROCHLORIDE 180MG FILM-COATED TABLETS 30S (115527 X 30S PACKS=3465810 NOS)NOS | $142.7K | 3 |
| FEXOFENADINE HYDROCHLORIDE 180MG FILM-COATED TABLETS 30S (115207 X 30S PACKS=3456210 NOS)NOS | $142.6K | 3 |
Dr.reddy's Laboratories Ltd exports 134 distinct Fexofenadine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FEXOFENADINE HYDROCHLORIDE 180MG FILM-CO with 29 shipments worth $1.2M. Notable combination products include fixed-dose combinations with other active ingredients, meeting diverse global regulatory requirements.
Regulatory Requirements: Exporting Fexofenadine to Key Markets
What Dr.reddy's Laboratories Ltd must comply with to export Fexofenadine to its top destination countries
United Kingdom — MHRA
Approval Process
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Australia — TGA
Approval Process
Registration on Australian Register of Therapeutic Goods (ARTG). Bioequivalence and quality data per TGA guidelines.
Timeline: 10–14 months
GMP & Export Requirements
TGA GMP clearance; PIC/S-aligned inspection. PIC/S certificate from India may expedite.
TGA sponsor licence for Australian importer; GMP clearance per manufacturing site
Note: TGA participates in PIC/S mutual recognition.
United States — FDA
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
How Does Dr.reddy's Laboratories Ltd Compare to Nearest Fexofenadine Exporters?
Exporters ranked immediately above and below #4 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 2 | IND SWIFT LIMITED | $14.6M | 524 | 12 | $27.8K |
| 3 | CIPLA LIMITED | $13.6M | 921 | 7 | $14.8K |
| 4 | DR.REDDY'S LABORATORIES LTD ★ | $12.4M | 249 | 5 | $50.0K |
| 1 | GRANULES INDIA LIMITED | $9.7M | 194 | 1 | $50.0K |
| 5 | SUN PHARMACEUTICAL INDUSTRIES LIMITED | $7.7M | 154 | 7 | $50.0K |
Dr.reddy's Laboratories Ltd ranks #4 among 224 Indian Fexofenadine exporters. Average shipment value of $50.0K compared to the market average of $365.5K. The closest competitors by value are IND SWIFT LIMITED and CIPLA LIMITED.
Which Indian Ports Ship Fexofenadine Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 569 | 13.4% |
| JNPT/ NHAVA SHEVA SEA | 385 | 9.1% |
| SAHAR AIR CARGO ACC (INBOM4) | 362 | 8.5% |
| NHAVA SHEVA SEA (INNSA1) | 350 | 8.3% |
| HYDERABAD ICD | 229 | 5.4% |
| CHAWAPAYAL ICD | 186 | 4.4% |
| JNPT | 161 | 3.8% |
| CHAWAPAYAL ICD (INCPR6) | 142 | 3.4% |
Market Intelligence
Latest developments and market context
Detailed market intelligence for Fexofenadine — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Fexofenadine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Dr.reddy's Laboratories Ltd matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 297 individual customs records matching Dr.reddy's Laboratories Ltd exporting Fexofenadine, covering 134 formulations to 5 countries via 19 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 97+ countries, 599+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Fexofenadine Export Data from Dr.reddy's Laboratories Ltd
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Dr.reddy's Laboratories Ltd's Fexofenadine exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Dr.reddy's Laboratories Ltd
Company Profile
0 products · $0 total trade · 0 categories
Fexofenadine Stats
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Dr.reddy's Laboratories Ltd.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Fexofenadine. For current shipment-level data, contact TransData Nexus.